120 related articles for article (PubMed ID: 1410576)
21. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers.
Robertson C; Robertson AG; Hendry JH; Roberts SA; Slevin NJ; Duncan WB; MacDougall RH; Kerr GR; O'Sullivan B; Keane TJ
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):319-29. PubMed ID: 9457816
[TBL] [Abstract][Full Text] [Related]
22. Dose, time, and fraction size issues for late effects in head and neck cancers.
Taylor JM; Mendenhall WM; Lavey RS
Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
[TBL] [Abstract][Full Text] [Related]
23. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
24. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
25. [Laryngeal cancer and conservative treatment. Place of combined radiotherapy chemotherapy and modified fractionation radiotherapy].
Brunin F; Rodriguez J; Jaulerry C
Bull Cancer; 1997 Feb; 84(2):191-8. PubMed ID: 9180844
[TBL] [Abstract][Full Text] [Related]
26. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
27. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
28. The hazard of accelerated tumor clonogen repopulation during radiotherapy.
Withers HR; Taylor JM; Maciejewski B
Acta Oncol; 1988; 27(2):131-46. PubMed ID: 3390344
[TBL] [Abstract][Full Text] [Related]
29. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
[TBL] [Abstract][Full Text] [Related]
30. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
31. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
Krstevska V; Crvenkova S
Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
[TBL] [Abstract][Full Text] [Related]
32. Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionation.
Okubo M; Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Tachibana I; Koike R; Nishikawa T; Mori K
Jpn J Clin Oncol; 2010 Oct; 40(10):944-8. PubMed ID: 20534687
[TBL] [Abstract][Full Text] [Related]
33. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
Fein DA; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
[TBL] [Abstract][Full Text] [Related]
34. Accelerated versus conventional radiation fractionation in early stage carcinoma larynx.
Alam MS; Perween R; Siddiqui SA
Indian J Cancer; 2016; 53(3):402-407. PubMed ID: 28244470
[TBL] [Abstract][Full Text] [Related]
35. [Timing and duration of postoperative radiotherapy in patients with laryngeal cancer].
Milecki P; Kruk-Zagajewska A; Stryczyńska G
Otolaryngol Pol; 2002; 56(3):307-11. PubMed ID: 12162018
[TBL] [Abstract][Full Text] [Related]
36. Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma.
Inoue T; Inoue T; Chatani M; Teshima T
Strahlenther Onkol; 1992 Jan; 168(1):23-6. PubMed ID: 1734586
[TBL] [Abstract][Full Text] [Related]
37. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
38. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
[TBL] [Abstract][Full Text] [Related]
39. Treatment of early and moderately advanced vocal cord carcinoma with 6-MV X-rays.
Parsons JT; Greene BD; Speer TW; Kirkpatrick SA; Barhorst DB; Yanckowitz T
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):953-9. PubMed ID: 11429223
[TBL] [Abstract][Full Text] [Related]
40. Conventional fractionation should not be the standard of care for T2 glottic cancer.
Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
